PCRXHealthcareSmall-Cap
Pacira BioSciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Pacira BioSciences, Inc. (PCRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are PCRX insiders buying or selling?
Pacira BioSciences, Inc. insiders reported 12 open-market buys ($871.6K) and 174 sells ($114.7M) across 186 Form 4 filings — a net selling position of $113.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 13, 2026)
Total Form 4 filings
186
SEC EDGAR
Insider filers
27
Insider buys (12)
$871.6K
Insider sells (174)
$114.7M
Insider sentiment
Net sellingNet insider flow of $113.8M in net selling.
Recent PCRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 13, 2026 | Lauren Riker | Senior Vice President, Finance | Sale | 6.1K | $23.50 | $143.7K |
| Jun 5, 2026 | Kristen Williams | Chief Administrative Officer | Sale | 10.3K | $22.27 | $228.5K |
| Apr 25, 2026 | Shawn Cross | Chief Financial Officer | Sale | 12.9K | $25.16 | $325.6K |
| Apr 23, 2026 | Shawn Cross | Chief Financial Officer | Sale | 12.1K | $25.09 | $302.6K |
| Mar 19, 2026 | Jonathan Slonin | Chief Medical Officer | Sale | 3.3K | $22.82 | $74.4K |
| Mar 19, 2026 | Mark Froimson | Director | Sale | 500 | $21.81 | $10.9K |
| Feb 3, 2026 | Lauren Riker | Senior Vice President, Finance | Sale | 4.0K | $20.81 | $83.2K |
| Feb 3, 2026 | Kristen Williams | Chief Administrative Officer | Sale | 13.1K | $20.53 | $269.7K |
| Jan 6, 2026 | Lauren Riker | Senior Vice President, Finance | Sale | 1.4K | $24.24 | $34.3K |
| Nov 19, 2025 | Jonathan Slonin | Chief Medical Officer | Sale | 4.0K | $24.09 | $95.4K |
| Nov 13, 2025 | Shawn Cross | Chief Financial Officer | Sale | 12.1K | $22.09 | $266.4K |
| Sep 8, 2025 | Abraham Ceesay | Director | Sale | 2.4K | $27.19 | $64.0K |
| Aug 11, 2025 | Marcelo Bigal | Director | Sale | 4.9K | $23.67 | $116.3K |
| Jun 5, 2025 | Lauren Riker | Senior Vice President, Finance | Sale | 5.6K | $26.21 | $146.2K |
| Jun 5, 2025 | Kristen Williams | Chief Administrative Officer | Sale | 14.4K | $26.24 | $377.2K |
| Jan 6, 2025 | Jonathan Slonin | Chief Medical Officer | Sale | 879 | $18.40 | $16.2K |
| Dec 16, 2024 | Daryl Gaugler | Chief Operating Officer | Sale | 500 | $19.76 | $9.9K |
| Sep 14, 2024 | Daryl Gaugler | Chief Operating Officer | Sale | 500 | $12.86 | $6.4K |
| Aug 19, 2024 | Marcelo Bigal | Director | Purchase | 1.5K | $13.25 | $20.0K |
| Aug 19, 2024 | Laura Brege | Director | Purchase | 1.0K | $12.81 | $12.8K |
| Aug 14, 2024 | Michael J. Yang | Director | Purchase | 2.0K | $12.90 | $25.8K |
| Aug 13, 2024 | Frank D. Lee | Chief Executive Officer | Purchase | 8.3K | $12.10 | $100.0K |
| Aug 13, 2024 | Marcelo Bigal | Director | Purchase | 3.4K | $12.01 | $40.8K |
| Aug 13, 2024 | Mark Froimson | Director | Purchase | 1.4K | $11.58 | $16.2K |
| Aug 13, 2024 | Marcelo Bigal | Director | Purchase | 3.4K | $12.01 | $40.8K |
Showing the 25 most recent of 186 Form 4 filings for Pacira BioSciences, Inc..
Most active PCRX insiders
- Lauren Riker32 filings
- Kristen Williams22 filings
- David M Stack18 filings
- Jonathan Slonin10 filings
- Max Reinhardt10 filings
Ask anything about PCRX insider activity
Use Trabud's AI agent to query Pacira BioSciences, Inc.'s Form 4 history in plain English — "Show me PCRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentPCRX insider trading FAQ
Are Pacira BioSciences, Inc. insiders buying or selling?
Across 186 SEC Form 4 filings, Pacira BioSciences, Inc. (PCRX) insiders reported 12 open-market purchases totaling $871.6K and 174 sales totaling $114.7M. That is a net selling position of $113.8M.
How many insiders trade PCRX stock?
27 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Pacira BioSciences, Inc.. The most recent filing was accepted on Jun 13, 2026.
Where does Trabud get PCRX insider trading data?
All PCRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.